So your position is: you'd rather have had Kevetrin be toxic, so that the Phase 1 trial was concluded earlier, rather than have it be so safe that it hasn't yet reached dose-limiting toxicity?

In other words, you wish that Kevetrin were less safe?

If you are unfortunate enough to get cancer, and fortunate to have a form that Kevetrin can treat if it is approved someday, I suspect that you will be mighty happy that it doesn't have significant side effects, even when taken in doses that are SEVENTY-FIVE TIMES the initial dose that was tested.

I find your position to be indefensible.